Pathophysiology and clinical implications of pulmonary arterial enlargement in COPD

by Wells, J Michael, Dransfield, Mark T
Published 2013

Acquired defects in CFTR-dependent β-adrenergic sweat secretion in chronic obstructive pulmonary disease

by Courville, Clifford A, Tidwell, Sherry, Liu, Bo, Accurso, Frank J, Dransfield, Mark T, Rowe, Steven M
Published 2014

Determinants of successful completion of pulmonary rehabilitation in COPD

by Brown, Angel T, Hitchcock, Jason, Schumann, Christopher, Wells, J Michael, Dransfield, Mark T, Bhatt, Surya P
Published 2016

Heritability of pulmonary function estimated from pedigree and whole-genome markers

by Klimentidis, Yann C., Vazquez, Ana I., de los Campos, Gustavo, Allison, David B., Dransfield, Mark T., Thannickal, Victor J.
Published 2013

Impact of heterozygote CFTR Mutations in COPD patients with Chronic Bronchitis

by Raju, S Vamsee, Tate, Jody H, Peacock, Sandra KG, Fang, Ping, Oster, Robert A, Dransfield, Mark T, Rowe, Steven M
Published 2014

Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations

by O'Reilly, Philip J, Jackson, Patricia L, Wells, J Michael, Dransfield, Mark T, Scanlon, Paul D, Blalock, J Edwin
Published 2013

Determinants of arterial stiffness in COPD

by Bhatt, Surya P, Cole, Adam G, Wells, James Michael, Nath, Hrudaya, Watts, Jubal R, Cockcroft, John R, Dransfield, Mark T
Published 2014

Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort

by Busch, Robert, Han, MeiLan K., Bowler, Russell P., Dransfield, Mark T., Wells, J Michael, Regan, Elizabeth A., Hersh, Craig P.
Published 2016

Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation

by Ohar, Jill A, Crater, Glenn D, Emmett, Amanda, Ferro, Thomas J, Morris, Andrea N, Raphiou, Ibrahim, Sriram, Peruvemba S, Dransfield, Mark T
Published 2014

Feasibility of exercising adults with asthma: a randomized pilot study

by Boyd, Amy, Yang, Celeste T, Estell, Kim, MS, Craig Tuggle, Gerald, Lynn B, Dransfield, Mark, Bamman, Marcas, Bonner, James, Atkinson, T Prescott, Schwiebert, Lisa M
Published 2012

β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol

by Bhatt, Surya P, Connett, John E, Voelker, Helen, Lindberg, Sarah M, Westfall, Elizabeth, Wells, J Michael, Lazarus, Stephen C, Criner, Gerard J, Dransfield, Mark T
Published 2016

A Pharmacologic Approach to Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Smoking Related Lung Disease

by Sloane, Peter A., Shastry, Suresh, Wilhelm, Andrew, Courville, Clifford, Tang, Li Ping, Backer, Kyle, Levin, Elina, Raju, S. Vamsee, Li, Yao, Mazur, Marina, Byan-Parker, Suzanne, Grizzle, William, Sorscher, Eric J., Dransfield, Mark T., Rowe, Steven M.
Published 2012

Clinical, physiologic, and radiographic factors contributing to development of hypoxemia in moderate to severe COPD: a cohort study

by Wells, J. Michael, Estepar, Raul San Jose, McDonald, Merry-Lynn N., Bhatt, Surya P., Diaz, Alejandro A., Bailey, William C., Jacobson, Francine L., Dransfield, Mark T., Washko, George R., Make, Barry J., Casaburi, Richard, van Beek, Edwin J. R., Hoffman, Eric A., Sciurba, Frank C., Crapo, James D., Silverman, Edwin K., Hersh, Craig P.
Published 2016